Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
PHASE2/PHASE3
200 participants
INTERVENTIONAL
2017-12-31
2018-03-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
The patients are divided randomly into two groups as follows:
* Group (A): undergoing blunt uterine incision expansion
* Group (B): undergoing sharp uterine incision expansion
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
OTHER
DOUBLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
• Group (A) blunt incision
100 primigravidas at term who underwent elective transverse lower segment Cesarean section for the first time among the age group of 20 - 37 years with a singleton pregnancy.
undergoing blunt uterine incision expansion
blunt uterine incision expansion
blunt uterine incision expansion
• Group (B) sharp incision
100 primigravidas, at term who underwent elective transverse lower segment Cesarean section for the first time among the age group of 20 - 37 years with a singleton pregnancy undergoing sharp uterine incision expansion
sharp uterine incision expansion
sharp uterine incision expansion
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
blunt uterine incision expansion
blunt uterine incision expansion
sharp uterine incision expansion
sharp uterine incision expansion
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
* any medical or psychiatric
* patients with BMI ≥ 40
* multigravidas
* chronic analgesia use,
* allergy to analgesics,
* multiple pregnancies are also excluded
20 Years
37 Years
FEMALE
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Kasr El Aini Hospital
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
sarah mohamed hassan
lecturer of obstetrics and gynecology
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Kasr El Ainiy Hospital
Cairo, , Egypt
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
336695
Identifier Type: -
Identifier Source: org_study_id